We present a case of a 21-year-old male diagnosed with difficult to treat idiopathic thrombocytopenia and autoimmune haemolytic anaemia at the age of 14. He initially improved with high doses of oral prednisone however relapsed at the age of 16, requiring multiple immunosuppressive agents, intravenous immunoglobulins (IVIG), splenectomy and Eltrombopag to induce remission. He was noted to have hypogammaglobulinemia and low memory B cells, however ongoing IVIG therapy precluded vaccine studies and functional antibody deficit could not be demonstrated.
We present a case of a 21-year-old male diagnosed with difficult to treat idiopathic thrombocytopenia and autoimmune haemolytic anaemia at the age of 14. He initially improved with high doses of oral prednisone however relapsed at the age of 16, requiring multiple immunosuppressive agents, intravenous immunoglobulins (IVIG), splenectomy and Eltrombopag to induce remission. He was noted to have hypogammaglobulinemia and low memory B cells, however ongoing IVIG therapy precluded vaccine studies and functional antibody deficit could not be demonstrated.
Five years later he presented to hospital with bilateral sixth nerve palsies, raised intracranial pressure and new, widespread lymphadenopathy. An inguinal lymph node biopsy revealed non-caseating granulomas. Although there was an initial resolution of ocular symptoms with high doses of prednisone, our patient re-presented 3 weeks later with bilateral lower limb weakness and several falls. MRI spine imaging revealed symmetrical granulomatous inflammation in the nerve roots of the cauda equina. Reexamination of the inguinal lymph node with further immunochemistry analysis revealed intact lymphoid tissue architecture and presence of plasma cells.
Sarcoidosis is an idiopathic, multi-system disorder that is characterised by non-caseating granulomas that are histologically indistinguishable from the lesions present in the granulomatous variant of common variable immunodeficiency. As the clinical features of the two disorders can also significantly overlap, the presence of plasma cells and normal architecture in the lymph node can be helpful in making the diagnosis. We discuss a rare case of neurosarcoidosis involving the peripheral nervous system and further outline diagnostic and management dilemmas. Background: Ataxia-telangiectasia (AT) is an autosomal recessive neurodegenerative disorder associated with immune deficiency and cancer susceptibility caused by a defect in the ataxia-telangiectasia mutated (ATM) gene resulting in impaired DNA repair. Lymphoma and leukaemia is the most commonly associated malignancy with childhood AT.
Case history: Our patient is a 10-year-old boy with genetically confirmed AT who has become progressively ataxic and was wheelchair dependent by 7 years of age. He has had recurrent pulmonary infections complicated by bronchiectasis with ongoing lymphopenia and impaired polysaccharide vaccine responses. His management has included intravenous immunoglobulin infusions, chest physiotherapy and Pneumocystis jiroveci prophylaxis.
At 11 years of age, he presented with left lower lobe pneumonia unresponsive to antibiotics, associated with night sweats, weight loss and an elevated LDH. A chest MRI revealed a 9.1-cm solid left lower lobe pulmonary mass with central necrosis and 1.6 cm splenic lesion. Biopsy of the pulmonary lesion demonstrated EBV positive, large atypical B lymphocytes (CD20+, Oct2+, MUM1+) within polymorphous T lymphocytes and histiocytes infiltrate, with central necrosis. This was consistent with grade 3 Lymphomatoid Granulomatosis (LG). He has responded well to reduce intensity chemotherapy with significant reduction in tumour size.
Conclusion:
Lymphomatoid granulomatosis is an EBV-associated angiodestructive B cell lymphoproliferative disease which typically presents in middle adulthood with pulmonary involvement in over 90% cases, followed by involvement of skin, brain and kidneys. It is rare in paediatrics and described more frequently in immune-compromised patients. Despite treatment, the cumulative 5-year mortality ranges from 50% to 65%, with a median survival of 14-16 months. An extensive literature search (Medline, PubMed) did not identify any reported cases of LG complicating AT; however; it is possible that as an early form of B cell lymphoma, this may have been classified simply as lymphoma in other case reports.
CPID 3 A DETERIORATION IN A PATIENT WITH C1Q DEFICIENCY AND SYSTEMIC LUPUS ERYTHEMATOSUS ASSOCIATED WITH EBV SEROCONVERSION
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A 12-year-old girl with congenital deficiency of complement C1q was diagnosed with systemic lupus erythematosus (SLE) at the age of 9. She initially had low grade skin disease, treated with hydroxychloroquine, and remained stable until the age of 12.
At age 12, she suffered a severe flare of SLE following primary EBV infection. Her symptoms included severe mouth ulcers and fevers with greatly elevated serum ferritin (23 567 μg/L). She was given fresh frozen plasma (FFP) containing C1q based on previous published case reports, as well as oral prednisolone. This led to resolution of the acute episode.
One week into the admission, she developed a generalised tonic clonic seizure and MRI brain showed changes in the cerebral white matter, hippocampus and basal ganglia. Clinically she demonstrated delay in her cognitive processing. She was managed with pulse intravenous methylprednisolone which led to improvement of her symptoms and the MRI changes. During a subsequent flare of mouth ulcers, fever and hyperferritinemia, she was given FFP and once again, this led to resolution of the acute episode. She is currently maintained on regular FFP, mycophenolate and low dose prednisolone, and notably while many features have settled, the peripheral cutaneous vasculitis remains troubling.
This case highlights the importance of the classical complement pathway in the pathogenesis of SLE, and the potential to replace a missing factor to treat the disease. The occurrence of a flare post-EBV-seroconversion in a patient whose disease is primarily driven by failure to clear immune complexes, suggests that the well documented relationship between EBV and paediatric SLE, may be more about immune complex production or removal, than about the development of autoimmunity. 
CPID 4 A CASE OF RECURRENT ONYCHOMYCOSIS WITHOUT AUTOIMMUNITY

